Public Perceptions of Recessive Carrier Testing in the Preconception and Prenatal Periods

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 44, Issue 6, 2015, Pages 717-725

  Shiroff, Jennifer J ^a   Nemeth, Lynne S ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Carrier screening; Chat room; Genetic testing; Preconception; Pregnancy; Prenatal; Social media

Indexed keywords

ADULT; ATTITUDE TO HEALTH; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMAN; MALE; PATIENT COMPLIANCE; PERCEPTION; PREGNANCY; PRENATAL CARE; PREPREGNANCY CARE; PREVENTION AND CONTROL; PROCEDURES; PSYCHOLOGY; PUBLIC HEALTH SERVICE; QUALITATIVE RESEARCH; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HETEROZYGOTE DETECTION; HUMANS; MALE; PATIENT COMPLIANCE; PERCEPTION; PRECONCEPTION CARE; PREGNANCY; PRENATAL CARE; QUALITATIVE RESEARCH; UNITED STATES;

EID: 84947426895     PISSN: 08842175     EISSN: 15526909     Source Type: Journal    
DOI: 10.1111/1552-6909.12764     Document Type: Article

References (40)

1. American College of Obstetricians and Gynecologists. (2007). Hemoglobinopathies in pregnancy. Practice Bulletin No. 78. Retrieved from http://www.acog.org/Search?Keyword=hemoglobinopathy
2. American College of Obstetricians and Gynecologists. (2011). Update on carrier screening for cystic fibrosis. Committee Opinion No. 486. Obstetrics & Gynecology, 117, 1028-1031. doi: 10.1097/AOG.0b013e31821922c2
3. Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., & ...Kingsmore, S. F. (2011). Carrier testing for severe childhood recessive diseases by next-generation sequencing. Science Translational Medicine, 3(65), 65ra4. doi:10.1126/scitranslmed.3001756
4. Botkin, J. R. (2009). Assessing the new criteria for newborn screening. Health Matrix, 19(1), 163-186. Retrieved from www.ncbi.nlm.nih.gov/pubmed/19459543
5. Bradley, E. H., Curry, L. A., & Devers, K. J. (2007). Qualitative data analysis for health services research: Developing taxonomy, themes, and theory. Health Services Research, 42(4), 1758-1772. doi: 10.1111/j.1475-6773.2006.00684.x
6. Burke, W., Tarini, B., Press, N. A., & Evans, J. P. (2011). Genetic screening. Epidemiologic Reviews, 33(1), 148-164. doi: 10.1093/epirev/mxr008
7. Centers for Disease Control and Prevention. (2010). Public health genomics, genomic testing. Retrieved from http://www.cdc.gov/genomics/gtesting/ACCE/
8. Counsyl. (2015). Family prep screen. Retrieved from https://www.counsyl.com/services/family-prep-screen/carrier-screening/
9. Elo, S., & Kyngas, H. (2008). The qualitative content analysis process. Journal of Advanced Nursing, 62(1), 107-115. doi: 10.1111/j.1365-2648.2007.04569.x
10. Founds, S. (2014). Innovations in prenatal genetic testing beyond the fetal karyotype. Nursing Outlook, 62(3), 212-218. doi:10.1016/j.outlook.2013.12.010
11. Genpath. (2012). Women's health - for physicians. Retrieved from http://www.genpathdiagnostics.com/womenshealth/inherigen/
12. Gilbert, L. K., & Omisore, F. (2009). Common questions about herpes: Analysis of chat-room transcripts. Herpes, 15(3), 57-61.
13. Graneheim, U. H., & Lundman, B. (2004). Qualitative content analysis in nursing research: Concepts, procedures, and measures to achieve trustworthiness. Nurse Education Today, 24(2), 105-112. doi:10.1016/j.nedt.2003.10.001
14. Grody, W. W., Cutting, G. R., Klinger, K. W., Richards, C. S., Watson, M. S., & Desnick, R. J. (2001). Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genetic Medicine, 3(2), 149-154.
15. Haddow, J. E., & Palomaki, G. E. (Eds) (2010). Population based prenatal screening for cystic fibrosis via carrier testing: ACCE review. Retrieved from www.cdc.gov/genomics/activities/FBR/ACCE.htm
16. Hill, M. K., Archibald, A. D., Cohen, J., & Metcalfe, S. A. (2010). A systematic review of population screening for fragile X syndrome. Genetic Medicine, 12(7), 396-410.
17. Hoffman-Goetz, L., & Donelle, L. (2007). Chat room computer-mediated support on health issues for Aboriginal women. Health Care for Women International, 28, 397-418. doi: 10.1080/07399330601180057
18. Kingsmore, S. F., Lantos, J. D., Dinwiddie, D. L., Miller, N. A., Soden, S. E., Farrow, E. G., & Saunders, C. J. (2012). Next-generation community genetics for low-and-middle-income countries. Genome Medicine, 4(3), 25-32. doi:10.1186/gm324
19. LabCorp. (2015). Inheritest carrier screen. Retrieved from https://www.labcorp.com/wps/portal/!ut/p/c1/04_SB8K8xLLM9MSSzPy8xBz9CP0os3h_U2cv30B_IwN_f3MDA88APyM_byN_Q3cfA30_j_zcVP2CbEdFAPxk0ls!/dl2/d1/L0lDU0lKSWdrbUEhIS9JRFJBQUlpQ2dBek15cXchL1lCSkoxTkExTkk1MC01RncvN19PNUNKTVFPMjBPTzcwMElQTjJOSzJPMUdENS9JX19fXzE!/?WCM_PORTLET=PC_7_O5CJMQO20OO700IPN2NK2O1GD5_WCM&WCM_GLOBAL_CONTEXT=/wps/wcm/connect/IntGeneticsLib/integratedgenetics/home/our+services/reproductive+testing/inheritest+carrier+screen
20. Lakeman, P., Plass, A. M., Henneman, L., Bezemer, P. D., Cornel, M. C., & ten Kate, L. P. (2009). Preconceptional ancestry-based carrier couple screening for cystic fibrosis and haemoglobinopathies: What determines the intention to participate or not and actual participation? European Journal of Human Genetics, 17(8), 999-1009. doi: 10.1038/ejhg.2009.1
21. Latendresse, G., & Deneris, A. (2015). An update on current prenatal testing options: First trimester and noninvasive prenatal testing. Journal of Midwifery & Women's Health, 60(1), 24-36. doi:10.1111/jmwh.12228
22. Macias, W., Lewis, L. S., & Smith, T. L. (2005). Health-related message boards/chat rooms on the web: Discussion content and implications for pharmaceutical sponsorships. Journal of Community Health, 10(3), 209-223.
23. Maxwell, S. J., Kyne, G., Molster, C., Barker, N. M., Ormsby, J., & O'Leary, P. (2011). Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members. Genetic Testing and Molecular Biomarkers, 15(3), 159-164. doi:10.1089/gtmb.2010.0121
24. McGowan, M. L., Cho, M. A., & Sharp, R. R. (2013). The changing landscape of carrier screening: Expanding technology and options? Health Matrix, 23(1), 15-33.
25. Mennuti, M. T. (2008). Genetic screening in reproductive health care. Clinical Obstetrics and Gynecology, 51(1), 3-23. doi: 10.1097/GRF.0b013e318160f241
26. Metcalfe, S. A. (2012). Carrier screening in preconception consultation in primary care. Journal of Community Genetics, 3(3), 193-203. doi: 10.1007/s12687-011-0071-z
27. Muscular Dystrophy Association. (2014). How are genetic disorders inherited? Retrieved from mda.org/publications/facts-about-genetics-and-NMDs/genetic-disorders-inherited
28. Natera. (2015). Genetic carrier screening. Retrieved from http://www.natera.com/genetic-carrier-testing-providers
29. National Institutes of Health. (2010). The genetic and rare disease information center. Retrieved from http://report.nih.gov/nihfactsheets/ViewFactSheet.aspx?csid=80
30. Nolan, M. T., Hodgin, M. B., Olsen, S. J., Coleman, J., Sauter, P. K., & Mennuti, M. T. (2008). Genetic screening in reproductive health care. Clinical Obstetrics and Gynecology, 51(1), 3-23. doi: 10.1097/GRF.0b013e318160f241
31. Pathway Genomics. (2014). Carrier status DNA insight. Retrieved from http://www.pathway.com/carrier-status-dna-insight/
32. Pew Research Center. (2013). Smartphone ownership reaches critical mass in the US. Retreived from news.cnet.com/8301-1035_3-57587932-94/smartphone-ownership-reaches-critical-mass-in-the-u.s/
33. Poppelaars, F. A., van der Wal, G., Braspenning, J. C., Cornel, M. C., Henneman, L., Langendam, M. W., & ten Kate, L. P. (2003). Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: A focus group study. Public Health, 117(6):396-403. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1931202
34. Sanderson, S., Zimmern, R., Kroese, M., Higgins, J., Patch, C., & Emory, J. (2005). How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genetics in Medicine, 7, 495-500. doi:10.1097/01.gim.0000179941.44494.73
35. Secretary's Advisory Committee on Genetic Testing. (2000). Enhancing the oversight of genetic tests: Recommendations of the SACGT. Retrieved from http://www4.od.nih.gov/oba/sacgt/reports/oversight_report.htm
36. Srinivasan, B. S., Evans, E. A., Flannick, J., Patterson, A. S., Chang, C.C., Pham, T., & ... Patrizio, P. (2010). A universal carrier test for the long tail of Mendelian disease. Reproductive Biomedicine Online, 21, 537-551. doi:10.1016/j.rbmo.2010.05.012
37. Watson, E. K., Williamson, R., & Chapple, J. (1991). Attitudes to carrier screening for cystic fibrosis: A survey of health care professionals, relatives of sufferers and other members of the public. British Journal of Genetic Practice, 41(347), 237-240. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1371586/
38. Weinreich, S. S., de Lange-de Klerk, E., Rijmen, F., Cornel, M., de Kinderen, M., & Plass, A. M. (2009). Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: A pilot study among the general public and primary care providers. BMC Public Health, 9(338), 1-9. Doi: 10.1186/1471-2458-9-338
39. Williams, P. H., Nemeth, L. S., Sanner, J. E., & Frazier, L. Q. (2013). Thematic analysis of cardiac care patients' explanations for declining contribution to a genomic research-based biobank. American Journal of Critical Care, 22(4), 320-327. doi: http://dx.doi.org/10.4037/ajcc2013838
40. World Health Organization. (2011). Community genetics services: Report of a WHO consultation on community genetics in low-and middle-income countries. Geneva. Retrieved from http://whqlibdoc.who.int/publications/2011/9789241501149_eng.pd